Exelixis Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

EXEL
Exelixis

Last Price:

34.85

Seasonality Move:

13.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Access The Stock Grader Trading Tool From "The King Of Quants"

More details here...

Exelixis Price Quote

$34.85

+0.20 (+0.58%)

(Updated: November 21, 2024 at 1:00 PM ET)

Exelixis Key Stats

Buy

Exelixis (EXEL) is a Buy

Day range:

$34.25 - $34.81

52-week range:

$19.20 - $36.60

Dividend yield:

P/E ratio:

53.11

P/S ratio:

4.99

P/B ratio:

4.33%

Volume:

1.8M

Avg. volume:

2.6M

1-year change:

65.55%

Market cap:

$9.9B

Revenue:

$1.8B

EPS:

$1.56

How Much Does Exelixis Make?

How Much Are Exelixis's Sales Annually?
EXEL Revenues are $1.8B
How Much Profit Does Exelixis's Make A Year?
EXEL net income is $207.8M

Is Exelixis Growing As A Company?

What Is Exelixis's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.14%
What Is Exelixis's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 121.66%

Exelixis Stock Price Performance

Did Exelixis Stock Go Up Last Month?
Exelixis share price went up by 19.9% last month
Did EXEL's Share Price Rise Over The Last Year?
EXEL share price rose by 65.55% over the past 1 year

What Is Exelixis 52-Week High & Low?

What Is Exelixis’s 52-Week High Share Price?
Exelixis has traded as high as $36.60 over the past 52 weeks
What Is Exelixis’s 52-Week Low Share Price?
Exelixis has traded as low as $19.20 over the past 52 weeks

Exelixis Price To Free Cash Flow

Is Exelixis Stock Overvalued?
Exelixis is trading at a price to free cash flow ratio of 25.66
Is Exelixis Stock Undervalued?
Exelixis EV to Free Cash Flow ratio is 21.41
What Is Exelixis’s Price Earnings Growth Ratio?
EXEL PEG ratio is 0.05
Is Exelixis Trading At A Premium To Earnings?
Exelixis EV to EBIT ratio is 14.25

Is It Risky To Buy Exelixis?

How Much Debt Does Exelixis Have?
Total long term debt quarterly is $0
How Much Cash Does Exelixis Have?
Cash and short term investments quarterly total is $1.2B
What Is Exelixis’s Book Value Per Share?
Book value per share is 7.96

Is Exelixis Cash Flow Positive?

What Is EXEL Cash Flow From Operations?
Cash flow from operations (TTM) is $470.3M
What Is Exelixis’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$646.9M
What Is Exelixis’s Cash Flow From Investing?
Cash flow from investing (TTM) is $38.2M

Exelixis Return On Invested Capital

Is Management Doing A Good Job?
EXEL return on invested capital is 20.97%
What Is Exelixis Return On Assets?
ROA measures how assets are converting to revenues and is 16.15%
What Is EXEL Return On Equity?
ROE is a measure of profitability and is 20.97%

Exelixis Earnings Date & Stock Price

What Is Exelixis's Stock Price Today?
A single share of EXEL can be purchased today for 34.65
What Is Exelixis’s Stock Symbol?
Exelixis trades on the nasdaq under the ticker symbol: EXEL
When Is Exelixis’s Next Earnings Date?
The next quarterly earnings date for Exelixis is scheduled on February 6, 2025
When Is EXEL's next ex-dividend date?
Exelixis's next ex-dividend date is November 21, 2024
How To Buy Exelixis Stock?
You can buy Exelixis shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Exelixis Competitors

Who Are Exelixis's Competitors?
Below is a list of companies who compete with Exelixis or are related in some way:
- ADMA Biologics Inc (ADMA)
- Catalyst Pharmaceuticals Inc (CPRX)
- Inovio Pharmaceuticals Inc (INO)
- Merck & Co Inc (MRK)
- Vericel Corp (VCEL)

Exelixis Dividend Yield

What Is EXEL Dividend Yield?
Exelixis’s dividend yield currently is 0%
What Is Exelixis’s Payout Ratio?
Exelixis’s payout ratio is 0%
When Did Exelixis Last Pay A Dividend?
The latest dividend pay date is November 21, 2024
What Is Exelixis’s Dividend Per Share?
Exelixis pays a dividend of $0.00 per share

Exelixis Analyst Estimates

	YoY Growth	Past Surprise
EPS:	12166.18%	12.02%
Revenue:	14.33%	10.04%

Analyst Recommendations

Buy Recommendations:	9
Hold Recommendations:	6
Sell Recommendations:	0
Price Target:	31.83
Downside from Last Price:	-8.14%

Major Shareholders

How many EXEL shares are owned by institutional investors?
376.4M EXEL shares are owned by institutional investors
How many EXEL shares are owned by insiders?
8.7M EXEL shares are owned by insiders